Tetrahydrocannabinol

TransGlobal Assets Inc. (TMSH) Releases Their 2021 Monster Elixir CBD Product Lines

Retrieved on: 
Wednesday, July 7, 2021
Euphoriants, Appetite stimulants, Entheogens, Clinical medicine, Drugs, Medicine, Cannabis smoking, Cannabis, Massage, Tetrahydrocannabinol

Pittsburgh, Pensilvania, July 07, 2021 (GLOBE NEWSWIRE) -- Transglobal Assets, Inc. (OTC Pink: TMSH)is pleased to announcethe release of its family of new and exciting, all-natural CBD products, coming to stores soon.

Key Points: 
  • Pittsburgh, Pensilvania, July 07, 2021 (GLOBE NEWSWIRE) -- Transglobal Assets, Inc. (OTC Pink: TMSH)is pleased to announcethe release of its family of new and exciting, all-natural CBD products, coming to stores soon.
  • He continues,The mission for Monster Elixir is to produce the finest CDB and THC-infusedproducts on the market, and we are armed with the right products.
  • Essential oils and organic butters infused with CBD will have your skin feeling soft and silky to the touch.
  • Well Leaf Care Massage Oil infused with CBD is ideal for warming and massaging tight muscles and alleviating soreness in joints.

CBD of Denver Reports $2.1M (USD) Revenue for June 2021 with Trailing 12-Month Revenue Surpassing $27M (USD)

Retrieved on: 
Wednesday, July 7, 2021
Antiemetics, Entheogens, Euphoriants, Medicinal plants, Branches of biology, Health sciences, Drugs, Tetrahydrocannabinol, Medical cannabis, Cannabis, Cannabidiol

"As of June 30, we generated trailing 12-month sales of more than $27 million (USD)," commented Marcel Gamma, CEO of CBD of Denver.

Key Points: 
  • "As of June 30, we generated trailing 12-month sales of more than $27 million (USD)," commented Marcel Gamma, CEO of CBD of Denver.
  • CBD of Denver, Inc., Rockflowr GmbH and Swiss Industry Ventures AG are now also on LinkedIn.
  • CBD of Denver, Inc. (OTC Pink: CBDD) a full-line CBD and Hemp oil company ("CBDD") and a producer and distributor of Cannabis and CBD products in Switzerland, Europe and the US.
  • Black Pearl CBD has 0% THC but is not an Isolate where the THC is stripped from the product rendering it ineffective.

Avicanna Executes Multi Year Agreement to Supply Brazilian Pharmaceutical Company with THC and CBD Cannabis Extracts

Retrieved on: 
Wednesday, July 7, 2021
Euphoriants, Psychoactive drugs, Entheogens, Medicinal plants, Drugs, Branches of biology, Appetite stimulants, Antiemetics, Tetrahydrocannabinol, Cannabis, Hemp, Effects of cannabis

Avicannas standardized CBD and THC Cannabis Extracts are to be utilized to produce a range of cannabis-derived products for the Brazilian market of 211 million people.

Key Points: 
  • Avicannas standardized CBD and THC Cannabis Extracts are to be utilized to produce a range of cannabis-derived products for the Brazilian market of 211 million people.
  • (SMGH), has executed a three (3) year master supply agreement with a leading Brazilian pharmaceutical company to supply industrial volumes of high THC and high CBD full spectrum psychoactive cannabis resin (the Cannabis Extracts).
  • Fulfillment of purchase orders for commercial batches in 2022, based on initial forecasts made by the Brazilian pharmaceutical company pursuant to the agreement, is expected to generate approximately CAD$4 million in revenue for Avicanna.
  • SMGHs product offerings include Cannabis Extracts as well as isolated CBD, THC, and CBG and standardized seeds, which are marketed under the Companys brand, Aureus.

Zynerba Pharmaceuticals to Present at the Ladenburg Thalmann Virtual Healthcare Conference

Retrieved on: 
Wednesday, July 7, 2021
Drugs, Thalmann, Tetrahydrocannabinol, Ladenburg, Cannabinoid, Psychoactive drugs, Neurochemistry

DEVON, Pa., July 07, 2021 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Armando Anido, Chairman and Chief Executive Officer of Zynerba, will present a company overview during the Ladenburg Thalmann Virtual Healthcare Conference on Wednesday, July 14, 2021 at 12:00 p.m.

Key Points: 
  • DEVON, Pa., July 07, 2021 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that Armando Anido, Chairman and Chief Executive Officer of Zynerba, will present a company overview during the Ladenburg Thalmann Virtual Healthcare Conference on Wednesday, July 14, 2021 at 12:00 p.m.
  • Investors interested in arranging a virtual meeting with the Companys management during the conference should contact the Ladenburg Thalmann conference coordinator.
  • A webcast of the presentation will be available under the Events & Webcasts tab of the Investors section of the Zynerba website at www.zynerba.com .
  • Zynerba Pharmaceuticals is the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders.

Verde Resources Partners With MRX Technologies To Distribute CBD Products In Europe, Asia Pacific And The U.S.

Retrieved on: 
Wednesday, July 7, 2021
Psychoactive drugs, Entheogens, Euphoriants, Drugs, Medicinal plants, Branches of biology, Appetite stimulants, Antiemetics, Tetrahydrocannabinol, Cannabis, Effects of cannabis, Medical cannabis

SEATTLE, July 7, 2021 /PRNewswire/ -- Verde Resources Inc. (OTCQB: VRDR) Verde Resources announced a partnership with MRX Technologies.

Key Points: 
  • SEATTLE, July 7, 2021 /PRNewswire/ -- Verde Resources Inc. (OTCQB: VRDR) Verde Resources announced a partnership with MRX Technologies.
  • The partnership includes an agreement for Verde Resources to white-label THC-free CBD products from MRX Technologies.
  • MRX is excited to work with Verde Resources, serving multiple markets, reaching consumers around the globe...
    Tetrahydrocannabinol (THC), is the main psychoactive ingredient in cannabis.
  • Verde Resources will distribute non-psychoactive, THC-free CBD products in Europe, Hong Kong and the United States.

Strongest Delta-8 THC Gummies Line Launched By BudPop

Retrieved on: 
Tuesday, July 6, 2021
Cannabinoids, Drugs, Psychoactive drugs, Delta-8-Tetrahydrocannabinol, Gummy candy, Tetrahydrocannabinol, Goody, Neurochemistry

Keeping in line with their reputation, they have now come forward with a brand-new line of strongest Delta-8 gummies .

Key Points: 
  • Keeping in line with their reputation, they have now come forward with a brand-new line of strongest Delta-8 gummies .
  • Euphoria-inducing, scrumptious, and infused with the goody-two shoes sister of Delta-9 THC Delta-8 these gummies have enabled BudPop to knock their competition out of the park.
  • The gummies are highly potent and induce a smoother, more relaxing effect than products which use Delta-9 THC.
  • Delta-8 products, especially gummies, are becoming insanely popular as of late, and BudPop is among the top brands in the space.

Cannabix Technologies Granted Cannabis Drug Detection Device Canadian Patent, Delivers THCBA to US Clinic

Retrieved on: 
Tuesday, July 6, 2021
Psychoactive drugs, Drugs, Appetite stimulants, Entheogens, Euphoriants, Clinical medicine, Cannabis, Alcohol law, Tetrahydrocannabinol, Drug test, Driving under the influence, Cannabinol

Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of 9-tetrahydrocannabinol (THC) - the psychoactive component of marijuana that causes impairment.

Key Points: 
  • Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of 9-tetrahydrocannabinol (THC) - the psychoactive component of marijuana that causes impairment.
  • The Company also reports that in June it delivered its THC Breath Analyzer (THCBA) to a clinic in the Northwestern, U.S. for beta testing.
  • The collaborating clinic has a robust drug testing operation and is one of the top drug testing providers to employers within its respective state.
  • Cannabix Technologies Inc. is a developer of marijuana breathalyzer technologies for law enforcement and the workplace.

New Premium Delta-8 Carts Launched by Exhale Wellness Today

Retrieved on: 
Tuesday, July 6, 2021
Psychoactive drugs, Euphoriants, Medicine, Tobacco, Antiemetics, Appetite stimulants, Entheogens, Electronic cigarettes, Delta-8-Tetrahydrocannabinol, Tetrahydrocannabinol, Electronic cigarette, Medical cannabis

Exhale Wellness has recently launched a commendable addition to this list, in the form of their new Delta-8 vape cartridges.

Key Points: 
  • Exhale Wellness has recently launched a commendable addition to this list, in the form of their new Delta-8 vape cartridges.
  • The demand for Delta-8 THC products has never been higher, with consumers appreciating the high-quality products offered by Exhale Wellness.
  • What makes Exhale Wellness vape carts stand out from the pack is the company's promise of an all-natural, organic vaping experience.
  • These reviews come as no surprise, considering how well reputed Exhale Wellness is in the cannabis/hemp industry for their Delta-8 THC products.

Captor Capital’s California Retail Cannabis Dispensaries to Carry Grapefruit’s Patented Hourglass THC/CBD Delivery Cream

Retrieved on: 
Tuesday, July 6, 2021
Health sciences, Drugs, Pharmacology, Entheogens, Euphoriants, Medicinal plants, Appetite stimulants, Antiemetics, Cannabis, Tetrahydrocannabinol, Effects of cannabis, Cannabinoid

Captors agreement to carry Grapefruits Hourglass delivery cream system in its retail outlets is a strong endorsement that the Hourglass system is a truly disruptive delivery technology that is in the process of fundamentally changing the way humans can safely ingest THC and other cannabinoids to obtain their unique holistic benefits.

Key Points: 
  • Captors agreement to carry Grapefruits Hourglass delivery cream system in its retail outlets is a strong endorsement that the Hourglass system is a truly disruptive delivery technology that is in the process of fundamentally changing the way humans can safely ingest THC and other cannabinoids to obtain their unique holistic benefits.
  • Furthermore, and most importantly, Grapefruit is the exclusive licensee of the Z-Pod Xerogel Silica Gel, which powers the Hourglass delivery cream system for cannabis products in North America.
  • Only Grapefruit possesses the know-how to manufacture the Hourglass timerelease delivery cream from the Xerogel Gel, and only Grapefruit-approved retailers, such as Captor, can sell the Hourglass time-release delivery cream in the United States, Canada and Mexico.
  • To purchase Grapefruits groundbreaking CBD delivery relief cream online, please visit: https://hourglassonlinestore.com/
    To learn more about Grapefruits new sustained-release Hourglass THC + Cannabinoid Topical Delivery Cream, please watch this promotional video:

Premium Delta-8 Products Launched by Exhale Wellness

Retrieved on: 
Monday, July 5, 2021
Songs, Drugs, Cannabinoids, Psychoactive drugs, Antiemetics, Delta-8-Tetrahydrocannabinol, Hemp, Wellness, Tetrahydrocannabinol, Exhale, Delta Air Lines

LOS ANGELES, July 5, 2021 /PRNewswire/ -- Exhale Wellness, a Los Angeles based hemp brand, has just launched its new premium line of Delta-8 products .

Key Points: 
  • LOS ANGELES, July 5, 2021 /PRNewswire/ -- Exhale Wellness, a Los Angeles based hemp brand, has just launched its new premium line of Delta-8 products .
  • Delta-8 THC products have experienced a meteoric rise in popularity these past few years, with Exhale Wellness being no stranger to this phenomenon.
  • Having brought several Delta-8 products to the market and gotten stellar reviews from customers, Exhale Wellness is currently one of the fastest growing brands in the space, and for a good reason.
  • Having been highly reviewed by its broad base of consumers, Exhale Wellness is recognized widely as a producer of premium quality hemp products.